AOTI Inc., a company that provides advanced wound care products, has announced new additions to its executive team: Kevin Burke as chief commercial officer and head of USA sales, Anthony Moffatt promoted to chief financial officer, and Despi Hardy’s promotion to clinical science liaison.

Previously, Burke served as vice president of market development with Cardiovascular Systems, Inc. (CSI), where he helped grow the company’s revenue to more than $200 million. Prior to CSI, Burke spent 11 years with Medtronic's spinal division in a variety of leadership positions, overseeing multiple sales operations, as well as new product launches driving therapy adoption into emerging market segments, according to a May 1 news release.

Moffatt will oversee all finance functions for both the United States and Irish arms of AOTI Inc. Previously, he was the director of finance and customer service for the company.

Hardy will oversee clinical evidence development and manage relationships with key opinion leader clinicians and researchers. She previously was clinical trials manager.

AOTI is a private company based in Oceanside, and Galway, Ireland, that provides solutions to resolve severe and chronic wounds worldwide.